Clinical trials in Uppsala – page 16

334 clinical trials in Uppsala, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Uppsala at a glance

334

clinical trials

Research sites5

Quick filters

334 trials in Uppsala

Open in trial search

Narcolepsy

Not yet recruiting

Investigational

Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Metastases to peritoneum

Not yet recruiting

InvestigationalNo placebo

Study of Radspherin® for Patients with Peritoneal Cancer from Colorectal Cancer After Surgery and Chemotherapy

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Radium-224 Adsorbed In Calcium Carbonate Microparticles
Sponsor:Oncoinvent Solutions AS

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness of Trastuzumab, Pertuzumab, and Docetaxel for Patients with Early HER2-Positive Breast Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Pertuzumab
Sponsor:HUS-yhtymae

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Registered drug

Study on Imatinib for Improving Recovery in Patients with Acute Ischemic Stroke

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Imatinib
Sponsor:Karolinska Institutet

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Registered drugNo placebo

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Sweden

Participants:65+ years
Substances:Cyclophosphamide
Sponsor:Region Skane

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

Investigational

Study on JNJ-64042056 for Preclinical Alzheimer's Disease in Patients

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Jnj-64042056
Sponsor:Janssen Cilag International

Contact Research Centre

Abortion induced

Not yet recruiting

Registered drugNo placebo

Study on Immediate vs. Delayed Insertion of Levonorgestrel IUD for Women After Medical Abortion

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Levonorgestrel
Sponsor:Karolinska Institutet

Contact Research Centre

Acute leukaemia+6

Not yet recruiting

Registered drug

Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

Registered drug

Sweden

Participants:0–17 years · 18–64 years
Substances:Triptorelin
Sponsor:Karolinska University Hospital

Contact Research Centre

Coeliac disease

Not recruiting

Investigational

Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Chronic kidney disease

Not recruiting

Registered drugNo placebo

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:AstraZeneca AB

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Guselkumab
Sponsor:Janssen Cilag International

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Uppsala

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on metastatic breast cancer and prostate cancer treatments, including targeted therapies and novel drug combinations.

Advanced breast cancer treatments
Prostate cancer therapies
Colorectal cancer studies

Particular emphasis on HER2-positive breast cancer imaging and treatment optimization.

02 Metabolic Disorders

Research initiatives targeting obesity management and metabolic health, with studies evaluating new therapeutic approaches for weight management in both adults and adolescents.

Weight management treatments
Adolescent obesity studies
Metabolic health interventions

Focus on innovative drug combinations and long-term effectiveness studies.

03 Cardiovascular and Renal Studies

Comprehensive research on heart failure prevention and chronic kidney disease management, investigating new therapeutic combinations.

Heart failure prevention
Kidney disease treatments
Hypertension management

Emphasis on combination therapies and preventive approaches.

Back to Sweden All countries